(DNTL) dentalcorp Holdings - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA24874B1085

DNTL: Dental, Health, Care, Services

Dentalcorp Holdings Ltd. (TO:DNTL) is a leading consolidator and operator of dental practices in Canada, with a proven track record of acquiring and partnering with dental clinics to enhance their operational efficiency and patient care. The company, founded in 2011 and headquartered in Toronto, has established itself as a key player in the Canadian dental care landscape.

From a financial perspective, Dentalcorp operates with a market capitalization of approximately 1.54 billion CAD, reflecting its significant scale and market presence. The company’s forward P/E ratio of 14.68 indicates expectations for future earnings growth, while its P/S ratio of 1.02 suggests that investors are valuing the company based on its revenue generation capabilities. Notably, the P/B ratio of 0.89 signals that the market is valuing the company’s assets at a slight discount relative to book value.

For investors and fund managers, Dentalcorp’s business model is noteworthy for its focus on consolidating a fragmented dental care market. By acquiring and partnering with dental practices, the company is able to achieve economies of scale, standardize care protocols, and invest in advanced technology and training for its network of clinics. This approach not only enhances patient outcomes but also positions the company to benefit from the growing demand for dental care services in Canada.

Additionally, Dentalcorp’s financial structure and operational strategy provide insights into its potential for long-term value creation. The company’s ability to integrate newly acquired practices into its network, coupled with its focus on optimizing clinical and administrative processes, underscores its commitment to sustainable growth and profitability. Investors should consider the company’s ability to maintain its growth trajectory, manage integration risks, and adapt to evolving regulatory and competitive dynamics in the Canadian healthcare sector.

Additional Sources for DNTL Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

DNTL Stock Overview

Market Cap in USD 1,095m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception

DNTL Stock Ratings

Growth Rating -38.9
Fundamental 32.8
Dividend Rating 0.0
Rel. Strength 25
Analysts -
Fair Price Momentum 6.96 CAD
Fair Price DCF 17.12 CAD

DNTL Dividends

No Dividends Paid

DNTL Growth Ratios

Growth Correlation 3m 19.2%
Growth Correlation 12m 17.5%
Growth Correlation 5y -70.3%
CAGR 5y -13.72%
CAGR/Max DD 5y -0.19
Sharpe Ratio 12m 0.78
Alpha 14.87
Beta 0.657
Volatility 33.83%
Current Volume 121.9k
Average Volume 20d 200k
What is the price of DNTL stocks?
As of April 19, 2025, the stock is trading at CAD 7.92 with a total of 121,900 shares traded.
Over the past week, the price has changed by +1.41%, over one month by +6.17%, over three months by +1.41% and over the past year by +24.33%.
Is dentalcorp Holdings a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, dentalcorp Holdings is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.83 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DNTL as of April 2025 is 6.96. This means that DNTL is currently overvalued and has a potential downside of -12.12%.
Is DNTL a buy, sell or hold?
dentalcorp Holdings has no consensus analysts rating.
What are the forecast for DNTL stock price target?
According to ValueRays Forecast Model, DNTL dentalcorp Holdings will be worth about 7.5 in April 2026. The stock is currently trading at 7.92. This means that the stock has a potential downside of -5.18%.
Issuer Forecast Upside
Wallstreet Target Price 12.5 58.2%
Analysts Target Price - -
ValueRay Target Price 7.5 -5.2%